The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome
Open accessAbstract
The use of small interfering RNAs (siRNAs) has been under investigation for the treatment of several unmet medical needs, including acute lung injury/acute respiratory distress syndrome (ALI/ARDS) wherein siRNA may be implemented to modify the expression of pro-inflammatory cytokines and chemokines at the mRNA level. The properties such as clear anatomy, accessibility, and relatively low enzyme activity make the lung a good target for local siRNA therapy. However, the translation of siRNA is restricted by the inefficient delivery of siRNA therapeutics to the target cells due to the properties of naked siRNA. Thus, this review will focus on the various delivery systems that can be used and the different barriers that need to be surmounted for the development of stable inhalable siRNA formulations for human use before siRNA therapeutics for ALI/ARDS become available in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Acute respiratory distress syndrome
Matthay, M. A., Zemans, R. L., Zimmerman, G. A., Arabi, Y. M., Beitler, J. R., Mercat, A., Herridge, M., Randolph, A. G., & Calfee, C. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0069-0 · Cited by 2,387
Advances in oligonucleotide drug delivery
Roberts, T. C., Langer, R., & Wood, M. J. A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0075-7 · Cited by 2,027
Acute respiratory distress syndrome
Thompson, B. T., Chambers, R. C., & Liu, K. D. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1608077 · Cited by 1,807
Therapeutic siRNA: state of the art
Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0207-x · Cited by 1,586
Ha, D., Yang, N., & Nadithe, V. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.02.001 · Cited by 1,346
Villar, J., Ferrando, C., Martínez, D., Ambrós, A., Muñoz, T., Soler, J. A., Aguilar, G., Alba, F., González-Higueras, E., Conesa, L. A., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30417-5 · Cited by 1,199
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081
Acute Lung Injury: A Clinical and Molecular Review
Butt, Y., Kurdowska, A., & Allen, T. C. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0519-ra · Cited by 894
Delivery of siRNA Therapeutics: Barriers and Carriers
Wang, J., Lu, Z., Wientjes, M. G., & Au, J. L.-S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9210-4 · Cited by 798
Immune Responses to Viral Gene Therapy Vectors
Shirley, J. L., de Jong, Y. P., Terhorst, C., & Herzog, R. W. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.001 · Cited by 788
Recent advances in polymeric drug delivery systems
Sung, Y. K., & Kim, S. W. (2020) · Biomaterials Research · doi:10.1186/s40824-020-00190-7 · Cited by 732
Papadakis, R. (2019) · Molecules · doi:10.3390/molecules25010001 · Cited by 662
Rapid translocation of nanoparticles from the lung airspaces to the body
Choi, H. S., Ashitate, Y., Lee, J. H., Kim, S. H., Matsui, A., Insin, N., Bawendi, M. G., Semmler-Behnke, M., Frangioni, J. V., & Tsuda, A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1696 · Cited by 648
Breaking down the barriers: siRNA delivery and endosome escape
Dominska, M., & Dykxhoorn, D. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.066399 · Cited by 630
Recent advancements in the use of exosomes as drug delivery systems
Bunggulawa, E. J., Wang, W., Yin, T., Wang, N., Durkan, C., Wang, Y., & Wang, G. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0403-9 · Cited by 589
Nunn's Applied Respiratory Physiology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-19398-1 · Cited by 514
The growth of siRNA-based therapeutics: updated clinical studies
Zhang, M. M., Bahal, R., Rasmussen, T. P., Manautou, J. E., & Zhong, X.-B. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114432 · Cited by 497
Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00697 · Cited by 466
Nanoparticle diffusion in respiratory mucus from humans without lung disease
Schuster, B. S., Suk, J. S., Woodworth, G. F., & Hanes, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.064 · Cited by 461
Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454
Liposomal siRNA nanocarriers for cancer therapy
Ozpolat, B., Sood, A. K., & Lopez-Berestein, G. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.008 · Cited by 442
Internalization mechanisms of cell-penetrating peptides
Ruseska, I., & Zimmer, A. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.10 · Cited by 436
siRNA Delivery Strategies: A Comprehensive Review of Recent Developments
Tatiparti, K., Sau, S., Kashaw, S., & Iyer, A. (2017) · Nanomaterials · doi:10.3390/nano7040077 · Cited by 429
Scott, L. J. (2020) · Drugs · doi:10.1007/s40265-020-01269-0 · Cited by 420
Kellner, M., Noonepalle, S., Lu, Q., Srivastava, A., Zemskov, E., & Black, S. M. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-63245-2_8 · Cited by 402
Acute respiratory distress syndrome
Sweeney, R. M., & McAuley, D. F. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00578-x · Cited by 398
The Role of Macrophages in the Pathogenesis of ALI/ARDS
Huang, X., Xiu, H., Zhang, S., & Zhang, G. (2018) · Mediators of Inflammation · doi:10.1155/2018/1264913 · Cited by 395
Recent advances in siRNA delivery mediated by lipid-based nanoparticles
Yonezawa, S., Koide, H., & Asai, T. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.022 · Cited by 378
Kendig's Disorders of the Respiratory Tract in Children
(2019) · Elsevier eBooks · doi:10.1016/c2015-0-01292-8 · Cited by 368
Rai, R., Alwani, S., & Badea, I. (2019) · Polymers · doi:10.3390/polym11040745 · Cited by 350
Oxygen Radical-Mediated Pulmonary Toxicity Induced by Some Cationic Liposomes
Dokka, S., Toledo, D., Shi, X., Castranova, V., & Rojanasakul, Y. (2000) · Pharmaceutical Research · doi:10.1023/a:1007504613351 · Cited by 349 · cited 1×
“It has been stated that the monovalent cationic lipids such as DOTAP are less toxic than the multivalent cationic lipids such as Lipofectamine (cid:2) , but also less efficient in packing and binding nucleic acids 115,125,141 .”
Gene Therapy Leaves a Vicious Cycle
Goswami, R., Subramanian, G., Silayeva, L., Newkirk, I., Doctor, D., Chawla, K., Chattopadhyay, S., Chandra, D., Chilukuri, N., & Betapudi, V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00297 · Cited by 347
Keeler, A. M., & Flotte, T. R. (2019) · Annual Review of Virology · doi:10.1146/annurev-virology-092818-015530 · Cited by 322
Exosomes as novel bio-carriers for gene and drug delivery
Jiang, X.-C., & Gao, J.-Q. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.038 · Cited by 321
The First Approved Gene Therapy Product for Cancer Ad- p53 (Gendicine): 12 Years in the Clinic
Zhang, W.-W., Li, L., Li, D., Liu, J., Li, X., Li, W., Xu, X., Zhang, M. J., Chandler, L. A., Lin, H., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.218 · Cited by 318
A review of inflammatory mechanism in airway diseases
Aghasafari, P., George, U., & Pidaparti, R. (2019) · Inflammation Research · doi:10.1007/s00011-018-1191-2 · Cited by 300
Shao, J., Zaro, J., & Shen, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s281890 · Cited by 295
Scott, L. J., & Keam, S. J. (2021) · Drugs · doi:10.1007/s40265-020-01463-0 · Cited by 292
siRNA therapeutics: a clinical reality
Saw, P. E., & Song, E.-W. (2020) · Science China Life Sciences · doi:10.1007/s11427-018-9438-y · Cited by 291
Fibroproliferation Occurs Early in the Acute Respiratory Distress Syndrome and Impacts on Outcome
MARSHALL, R. P., BELLINGAN, G., WEBB, S., PUDDICOMBE, A., GOLDSACK, N., McANULTY, R. J., & LAURENT, G. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.2001061 · Cited by 285
Capsid modifications for targeting and improving the efficacy of AAV vectors
Büning, H., & Srivastava, A. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.01.008 · Cited by 260
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
Sajid, M. I., Moazzam, M., Kato, S., Yeseom Cho, K., & Tiwari, R. K. (2020) · Pharmaceuticals · doi:10.3390/ph13100294 · Cited by 252
Designer Exosomes: A New Platform for Biotechnology Therapeutics
Jafari, D., Shajari, S., Jafari, R., Mardi, N., Gomari, H., Ganji, F., Forouzandeh Moghadam, M., & Samadikuchaksaraei, A. (2020) · BioDrugs · doi:10.1007/s40259-020-00434-x · Cited by 250
Sutherland, A., Thomas, M., Brandon, R. A., Brandon, R. B., Lipman, J., Tang, B., McLean, A., Pascoe, R., Price, G., Nguyen, T., et al. (2011) · Critical Care · doi:10.1186/cc10274 · Cited by 243
He, W., Kapate, N., Shields, C. W., & Mitragotri, S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.12.001 · Cited by 236
Self-citationPhysicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery
Liu, Q., Guan, J., Qin, L., Zhang, X., & Mao, S. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.023 · Cited by 229
Zhang, D., Wang, J., & Xu, D. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.020 · Cited by 227
Polymeric vehicles for nucleic acid delivery
Piotrowski-Daspit, A. S., Kauffman, A. C., Bracaglia, L. G., & Saltzman, W. M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.014 · Cited by 224
Peptides for nucleic acid delivery
Lehto, T., Ezzat, K., Wood, M. J. A., & EL Andaloussi, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.008 · Cited by 220
Delivery systems for siRNA drug development in cancer therapy
Xu, C.-F., & Wang, J. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.08.011 · Cited by 219
Pulmonary delivery of therapeutic siRNA
Lam, J. K.-W., Liang, W., & Chan, H.-K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.006 · Cited by 216
Gessner, I., & Neundorf, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072536 · Cited by 212
Phenotypes and personalized medicine in the acute respiratory distress syndrome
Matthay, M. A., Arabi, Y. M., Siegel, E. R., Ware, L. B., Bos, L. D. J., Sinha, P., Beitler, J. R., Wick, K. D., Curley, M. A. Q., Constantin, J.-M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06296-9 · Cited by 212
Biological drug and drug delivery-mediated immunotherapy
Xiao, Q., Li, X., Li, Y., Wu, Z., Xu, C., Chen, Z., & He, W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.018 · Cited by 211
Self-citation(2019) · Elsevier eBooks · doi:10.1016/c2016-1-05231-8 · Cited by 198
Exosomes as drug delivery systems: A brief overview and progress update
Patil, S. M., Sawant, S. S., & Kunda, N. K. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.07.026 · Cited by 190
Nanotechnology-based approaches for targeting and delivery of drugs and genes
Mishra, V. K., Kesharwani, P., Amin, M. C. I. M., & Iyer, A. K. (2017) · Cited by 181
Influence of physical properties of carrier on the performance of dry powder inhalers
Peng, T., Lin, S., Niu, B., Wang, X., Huang, Y., Zhang, X., Li, G., Pan, X., & Wu, C. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.03.011 · Cited by 176
Journey of siRNA: Clinical Developments and Targeted Delivery
Nikam, R. R., & Gore, K. R. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0715 · Cited by 176
Nanocarrier‐Mediated Cytosolic Delivery of Biopharmaceuticals
He, W., Xing, X., Wang, X., Wu, D., Wu, W., Guo, J., & Mitragotri, S. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910566 · Cited by 176
Self-citationThe potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress
Dua, K., Wadhwa, R., Singhvi, G., Rapalli, V., Shukla, S. D., Shastri, M. D., Gupta, G., Satija, S., Mehta, M., Khurana, N., et al. (2019) · Drug Development Research · doi:10.1002/ddr.21571 · Cited by 175
Clinical advances of siRNA therapeutics
Hu, B., Weng, Y., Xia, X., Liang, X., & Huang, Y. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3097 · Cited by 172
Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines
Guo, Y., Bera, H., Shi, C., Zhang, L., Cun, D., & Yang, M. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.015 · Cited by 169
Corticosteroids in Acute Lung Injury: The Dilemma Continues
Mokra, D., Mikolka, P., Kosutova, P., & Mokry, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194765 · Cited by 166
Ge, C., Yang, J., Duan, S., Liu, Y., Meng, F., & Yin, L. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04957 · Cited by 163
Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics
McClorey, G., & Banerjee, S. (2018) · Biomedicines · doi:10.3390/biomedicines6020051 · Cited by 160
Exosome-Mediated Small RNA Delivery: A Novel Therapeutic Approach for Inflammatory Lung Responses
Zhang, D., Lee, H., Wang, X., Rai, A., Groot, M., & Jin, Y. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.06.007 · Cited by 160
Delivery strategies of amphotericin B for invasive fungal infections
Wang, X., Mohammad, I. S., Fan, L., Zhao, Z., Nurunnabi, M., Sallam, M. A., Wu, J., Chen, Z., Yin, L., & He, W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.010 · Cited by 160
Self-citationCell Penetrating Peptides, Novel Vectors for Gene Therapy
Taylor, R. E., & Zahid, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030225 · Cited by 159
Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer
Khan, M. M., Filipczak, N., & Torchilin, V. P. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.028 · Cited by 159
Nanostructures in Drug Delivery
Tammam, S. N., & Lamprecht, A. (2016) · Wiley eBooks · doi:10.1002/9783527800681.ch6 · Cited by 155
siRNA based drug design, quality, delivery and clinical translation
Subhan, M. A., & Torchilin, V. P. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102239 · Cited by 154
Nanocarriers for Drug Delivery
(2018) · Elsevier eBooks · doi:10.1016/c2017-0-00199-4 · Cited by 151
Polymer-Based Nanomaterials for Drug-Delivery Carriers
Yadav, H. K. S., Almokdad, A. A., shaluf, S. I. M., & Debe, M. S. (2019) · Nanocarriers for Drug Delivery · doi:10.1016/b978-0-12-814033-8.00017-5 · Cited by 148 · cited 1×
“Their biocompatibility, low toxicity, and relatively high stability make them attractive deliverysystems 165 .”
Applications of Targeted Nano Drugs and Delivery Systems
(2018) · Elsevier eBooks · doi:10.1016/c2017-0-00274-4 · Cited by 146
Lechanteur, A., Sanna, V., Duchemin, A., Évrard, B., Mottet, D., & Piel, G. (2018) · Nanomaterials · doi:10.3390/nano8050270 · Cited by 140
siRNA Delivery to the lung: What's new?
Merkel, O. M., Rubinstein, I., & Kissel, T. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.018 · Cited by 138
The acute respiratory distress syndrome: fibrosis in the fast lane
Marshall, R. P., Bellingan, G. J., & Laurent, G. J. (1998) · Thorax · doi:10.1136/thx.53.10.815 · Cited by 138
Acute Respiratory Distress Syndrome: Etiology, Pathogenesis, and Summary on Management
Kaku, S., Nguyen, C. D., Htet, N. N., Tutera, D., Barr, J., Paintal, H. S., & Kuschner, W. G. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066619855021 · Cited by 135
Peptide-based gene delivery vectors
Kang, Z., Meng, Q., & Liu, K. (2019) · Journal of Materials Chemistry B · doi:10.1039/c8tb03124j · Cited by 124
Polymeric micelles as mighty nanocarriers for cancer gene therapy: a review
Yousefpour Marzbali, M., & Yari Khosroushahi, A. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3273-1 · Cited by 115
Current and evolving standards of care for patients with ARDS
Menk, M., Estenssoro, E., Sahetya, S. K., Neto, A. S., Sinha, P., Slutsky, A. S., Summers, C., Yoshida, T., Bein, T., & Ferguson, N. D. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06299-6 · Cited by 113
First AAV gene therapy poised for landmark approval
Smalley, E. (2017) · Nature Biotechnology · doi:10.1038/nbt1117-998 · Cited by 112
Principles of Pulmonary Medicine
(2019) · Elsevier eBooks · doi:10.1016/c2015-0-04760-8 · Cited by 109
Kusumoto, K., Akita, H., Ishitsuka, T., Matsumoto, Y., Nomoto, T., Furukawa, R., El‐Sayed, A., Hatakeyama, H., Kajimoto, K., Yamada, Y., et al. (2013) · ACS Nano · doi:10.1021/nn401317t · Cited by 109
Wang, J., Hanafy, M. S., Xu, H., Leal, J., Zhai, Y., Ghosh, D., Williams, R. O., Smyth, H. D. C., & Cui, Z. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120215 · Cited by 105
Bohr, A., Tsapis, N., Andreana, I., Chamarat, A., Foged, C., Deloménie, C., Noiray, M., Brahmi, N. E., Majoral, J., Mignani, S. M., et al. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00572 · Cited by 102
siRNA Conjugated Nanoparticles—A Next Generation Strategy to Treat Lung Cancer
Itani, R., & Faraj, A. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236088 · Cited by 102
Polymeric siRNA gene delivery – transfection efficiency versus cytotoxicity
Kargaard, A., Sluijter, J. P. G., & Klumperman, B. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.046 · Cited by 101
Development of human respiratory airway models: A review
Ahookhosh, K., Pourmehran, O., Aminfar, H., Mohammadpourfard, M., Sarafraz, M. M., & Hamishehkar, H. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105233 · Cited by 100
Alternative and Natural Therapies for Acute Lung Injury and Acute Respiratory Distress Syndrome
Patel, V. J., Roy, S. B., Mehta, H. J., Joo, M., & Sadikot, R. T. (2018) · BioMed Research International · doi:10.1155/2018/2476824 · Cited by 99
RNAi Therapeutic Platforms for Lung Diseases
Fujita, Y., Takeshita, F., Kuwano, K., & Ochiya, T. (2013) · Pharmaceuticals · doi:10.3390/ph6020223 · Cited by 97
The long-lasting effects of the acute respiratory distress syndrome
Mart, M. F., & Ware, L. B. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1743182 · Cited by 90
Magnetofection: Magic magnetic nanoparticles for efficient gene delivery
Bi, Q., Song, X., Hu, A., Luo, T., Jin, R., Ai, H., & Nie, Y. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.07.030 · Cited by 90
PEI fluorination reduces toxicity and promotes liver-targeted siRNA delivery
Xue, L., Yan, Y., Kós, P., Chen, X., & Siegwart, D. J. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00790-9 · Cited by 86
Therapeutic use of mesenchymal stem cell–derived extracellular vesicles in acute lung injury
Lee, J. H., Park, J.-H., & Lee, J. W. (2018) · Transfusion · doi:10.1111/trf.14838 · Cited by 85
How Should Aerosols Be Delivered During Invasive Mechanical Ventilation?
Dhand, R. (2017) · Respiratory Care · doi:10.4187/respcare.05803 · Cited by 84
Bohr, A., Tsapis, N., Foged, C., Andreana, I., Yang, M., & Fattal, E. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.08.009 · Cited by 82
Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges
Ding, L., Tang, S., Wyatt, T. A., Knoell, D. L., & Oupický, D. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.005 · Cited by 82
Lessons to learn from epidemiologic studies in ARDS
McNicholas, B., Rooney, G. M., & Laffey, J. G. (2017) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000473 · Cited by 80
Elwakil, M. M. A., Khalil, I. A., Elewa, Y. H. A., Kusumoto, K., Sato, Y., Shobaki, N., Kon, Y., & Harashima, H. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201807677 · Cited by 80
The Future of Pharmaceutical Product Development and Research
(2020) · Elsevier eBooks · doi:10.1016/c2017-0-01075-3 · Cited by 79
Delivery of RNAi Therapeutics to the Airways—From Bench to Bedside
Qiu, Y., Lam, J. K. W., Leung, S. W. S., & Liang, W. (2016) · Molecules · doi:10.3390/molecules21091249 · Cited by 77
d’Angelo, I., Costabile, G., Durantie, E., Brocca, P., Rondelli, V., Russo, A., Russo, G., Miro, A., Quaglia, F., Petri‐Fink, A., et al. (2017) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2017.1364 · Cited by 77
Aerosol delivery during invasive mechanical ventilation: a systematic review
Dugernier, J., Ehrmann, S., Sottiaux, T. M., Roeseler, J., Wittebole, X., Dugernier, T., Jamar, F., Laterre, P., & Reychler, G. (2017) · Critical Care · doi:10.1186/s13054-017-1844-5 · Cited by 76
A retro-inverso cell-penetrating peptide for siRNA delivery
Vaissière, A., Aldrian, G., Konate, K., Lindberg, M. F., Jourdan, C., Telmar, A., Seisel, Q., Fernandez, F., Viguier, V., Genevois, C., et al. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0269-2 · Cited by 74
Versatility of cell-penetrating peptides for intracellular delivery of siRNA
Singh, T. P., Murthy, A. S. N., Yang, H.-J., & Im, J. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1543366 · Cited by 74
Ju, Z., Ma, J., Wang, C., Yu, J., Qiao, Y., & Hei, F. (2016) · Inflammation · doi:10.1007/s10753-016-0494-0 · Cited by 72
Future Trends in Nebulized Therapies for Pulmonary Disease
McCarthy, S., González, H. E., & Higgins, B. D. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10020037 · Cited by 72
Solid Lipid Nanoparticles for Targeting and Delivery of Drugs and Genes
Tekade, R. K., Maheshwari, R., Tekade, M., & Chougule, M. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809717-5.00010-5 · Cited by 66
Trends in the biological functions and medical applications of extracellular vesicles and analogues
Zhao, Y., Li, X., Zhang, W., Yu, L., Wang, Y., Deng, Z., Liu, M., Mo, S., Wang, R., Zhao, J., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.012 · Cited by 66
Peptide-Based Nanoassemblies in Gene Therapy and Diagnosis: Paving the Way for Clinical Application
Tarvirdipour, S., Huang, X., Mihali, V., Schoenenberger, C., & Palivan, C. G. (2020) · Molecules · doi:10.3390/molecules25153482 · Cited by 65
Backer, L. D., Cerrada, A., Pérez‐Gil, J., Smedt, S. C. D., & Raemdonck, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.004 · Cited by 64
An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene Therapy
Duncan, G. A., Kim, N., Colon-Cortes, Y., Rodriguez, J., Mazur, M., Birket, S. E., Rowe, S. M., West, N. E., Livraghi-Butrico, A., Boucher, R. C., et al. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.03.006 · Cited by 64
Yang, J., Duan, S., Ye, H., Ge, C., Piao, C., Chen, Y., Lee, M., & Yin, L. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202008960 · Cited by 62
Combined delivery of HMGB-1 box A peptide and S1PLyase siRNA in animal models of acute lung injury
Oh, B., & Lee, M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.008 · Cited by 60
Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease
Marquez Loza, L. I., Yuen, E. C., & McCray, P. B. (2019) · Genes · doi:10.3390/genes10030218 · Cited by 59
Pathophysiology and Management of Acute Respiratory Distress Syndrome in Children
Heidemann, S. M., Nair, A., Bulut, Y., & Sapru, A. (2017) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2017.06.004 · Cited by 58
Yu, Z., Liu, X., Chen, H., & Zhu, L. (2020) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2019.1569 · Cited by 58
Liang, W., Chow, M. Y. T., Chow, S. F., Chan, H., Kwok, P. C. L., & Lam, J. K. W. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.045 · Cited by 56
Combining Fluorination and Bioreducibility for Improved siRNA Polyplex Delivery
Chen, G., Wang, K., Hu, Q., Ding, L., Yu, F., Zhou, Z., Zhou, Y., Li, J., Sun, M., & Oupický, D. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b14184 · Cited by 55
Dormenval, C., Lokras, A. G., Cano-Garcia, G., Wadhwa, A., Thanki, K., Rose, F., Thakur, A., Franzyk, H., & Foged, C. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2663-y · Cited by 55
Local delivery of siRNA-loaded calcium phosphate nanoparticles abates pulmonary inflammation
Frede, A., Neuhaus, B., Knuschke, T., Wadwa, M., Kollenda, S., Klopfleisch, R., Hansen, W., Buer, J., Bruder, D., Epple, M., et al. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.08.001 · Cited by 54
Inhalable siRNA-loaded nano-embedded microparticles engineered using microfluidics and spray drying
Agnoletti, M., Bohr, A., Thanki, K., Wan, F., Zeng, X., Boetker, J. P., Yang, M., & Foged, C. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.08.001 · Cited by 53
A summary on non-viral systems for gene delivery based on natural and synthetic polymers
Sarvari, R., Nouri, M., Agbolaghi, S., Roshangar, L., Sadrhaghighi, A., Seifalian, A. M., & Keyhanvar, P. (2020) · International Journal of Polymeric Materials · doi:10.1080/00914037.2020.1825081 · Cited by 52
Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems
Youngren-Ortiz, S. R., Gandhi, N. S., España‐Serrano, L., & Chougule, M. B. (2015) · KONA Powder and Particle Journal · doi:10.14356/kona.2016014 · Cited by 51
Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease
Teng, C., Lin, C., Huang, F., Xing, X., Chen, S., Ye, L., Azevedo, H. S., Xu, C., Wu, Z., Chen, Z., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.06.005 · Cited by 51
Self-citationInhalation therapies in acute respiratory distress syndrome
Artigas, A., Camprubí–Rimblas, M., Tantinyà, N., Bringué, J., Guillamat‐Prats, R., & Matthay, M. A. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.07.21 · Cited by 49
Ji, Q., Hou, J., Yong, X., Gong, G., Muddassir, M., Tang, T., Xie, J., Fan, W., & Chen, X. S. (2021) · Advanced Materials · doi:10.1002/adma.202007798 · Cited by 49
Clinical Review: Gene-based therapies for ALI/ARDS: where are we now?
Devaney, J., Contreras, M., & Laffey, J. G. (2011) · Critical Care · doi:10.1186/cc10216 · Cited by 48
Wang, Y., Ding, L., Li, Z., Chen, G., Sun, M., & Oupický, D. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.030 · Cited by 48
Xu, B., Chen, S.-S., Liu, M., Gan, C.-X., Li, J., & Guo, G.-H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117766 · Cited by 48
Design of Nanostructures for Versatile Therapeutic Applications
Grumezescu, A. M. (2018) · Elsevier eBooks · doi:10.1016/c2016-0-04096-2 · Cited by 47
Hou, J., Ji, Q., Ji, J., Ju, S., Xu, C., Yong, X., Xu, X., Muddassir, M., Chen, X., Xie, J., et al. (2021) · Theranostics · doi:10.7150/thno.54217 · Cited by 45
Lin, X., & Dean, D. A. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2011.04.002 · Cited by 44
Polymers in Drug Delivery: An Update
Bhatt, P., Trehan, S., Inamdar, N., Mourya, V. K., & Misra, A. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819659-5.00001-x · Cited by 43
siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes
Hattori, Y., Nakamura, A., Arai, S., Kawano, K., Maitani, Y., & Yonemochi, E. (2014) · Journal of Liposome Research · doi:10.3109/08982104.2014.992024 · Cited by 42
Pulmonary Delivery of siRNA As a Novel Treatment for Lung Diseases
Kandil, R., & Merkel, O. M. (2019) · Therapeutic Delivery · doi:10.4155/tde-2019-0009 · Cited by 42
Lyophilization and nebulization of pulmonary surfactant-coated nanogels for siRNA inhalation therapy
Merckx, P., Lammens, J., Nuytten, G., Bogaert, B., Guagliardo, R., Maes, T., Vervaet, C., Beer, T. D., Smedt, S. C. D., & Raemdonck, K. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.09.011 · Cited by 41
In vivo therapeutic applications of phosphorus dendrimers: state of the art
Mignani, S. M., Shi, X., Ceña, V., Shcharbin, D., Bryszewska, M. J., & Majoral, J. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.11.034 · Cited by 41
The Basic Science and Molecular Mechanisms of Lung Injury and Acute Respiratory Distress Syndrome
Aranda‐Valderrama, P., & Kaynar, A. M. (2017) · International Anesthesiology Clinics · doi:10.1097/aia.0000000000000177 · Cited by 38
Qin, S., Wang, H., Liu, G., Mei, H., & Chen, M. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10779 · Cited by 38
Fu, P., Usatyuk, P. V., Lele, A., Harijith, A. K., Gregorio, C. C., Garcia, J. G. N., Salgia, R., & Natarajan, V. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00306.2014 · Cited by 37
Polymer-based nanocarriers for therapeutic nucleic acids delivery
Yuan, W., & Li, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00014-2 · Cited by 36
Dong, J., Liao, W., Tan, L. H., Yong, A., Peh, W. Y., & Wong, W. S. F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.016 · Cited by 36
Hattori, Y., Tamaki, K., Ozaki, K., Kawano, K., & Onishi, H. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.06.016 · Cited by 36
Lipid/polymer-based nanocomplexes in nucleic acid delivery as cancer vaccines
Beg, S., Almalki, W. H., Khatoon, F., Alharbi, K. S., Alghamdi, S. A., Akhter, M. H., Khalilullah, H., Baothman, A. A., Hafeez, A., Rahman, M., et al. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.013 · Cited by 36
Exposure to Engineered Nanomaterials in the Environment
(2019) · Elsevier eBooks · doi:10.1016/c2017-0-01491-x · Cited by 34
Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems
Youngren-Ortiz, S. R., Gandhi, N. S., España‐Serrano, L., & Chougule, M. B. (2016) · KONA Powder and Particle Journal · doi:10.14356/kona.2017005 · Cited by 33
An Overview of Various Carriers for siRNA Delivery
Marquez, A. R., Madu, C. O., & Lu, Y. W. (2018) · Oncomedicine · doi:10.7150/oncm.25785 · Cited by 33
Xu, S., Yang, Q., Bai, J., Tao, T., Tang, L., Chen, Y., Chung, C., Fallon, E. A., & Ayala, A. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00108.2019 · Cited by 33
Toxicological exploration of peptide-based cationic liposomes in siRNA delivery
Zhu, Y., Meng, Y., Zhao, Y., Zhu, J., Xu, H., Zhang, E. X., Shi, L., Du, L., Liu, G., Zhang, C., et al. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.03.052 · Cited by 32
Nanocarriers in Effective Pulmonary Delivery of siRNA: Current Approaches and Challenges
Bardoliwala, D., Patel, V., Javia, A., Ghosh, S., Patel, A., & Misra, A. R. (2019) · Therapeutic Delivery · doi:10.4155/tde-2019-0012 · Cited by 32
He, W., Turkeshi, A., Li, X., & Zhang, H. (2020) · Therapeutic Delivery · doi:10.4155/tde-2020-0052 · Cited by 32
Self-citationPeptide photocaging: A brief account of the chemistry and biological applications
So, W. H., Wong, C. T. T., & Xia, J. (2018) · Chinese Chemical Letters · doi:10.1016/j.cclet.2018.05.015 · Cited by 31
High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin
Chow, M. Y. T., Qiu, Y., Liao, Q., Kwok, P. C. L., Chow, S. F., Chan, H., & Lam, J. K. W. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118818 · Cited by 31
Shcharbin, D., Bryszewska, M. J., Mignani, S. M., Shi, X., & Majoral, J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112788 · Cited by 30
Helal, H. M., Mortada, S. M., & Sallam, M. A. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0657-1 · Cited by 29
Self-citationAcute Lung Injury: Disease Modelling and the Therapeutic Potential of Stem Cells
Lian, J., Lin, J., Zakaria, N., & Yahaya, B. H. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_538 · Cited by 29
Nanotechnology approaches to pulmonary drug delivery
Gaul, R., Ramsey, J. M., Heise, A., Cryan, S., & Greene, C. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813667-6.00006-1 · Cited by 28
Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination
McCright, J., & Maisel, K. (2019) · Tissue Barriers · doi:10.1080/21688370.2019.1695476 · Cited by 28
Formulation of RNA interference-based Drugs for Pulmonary delivery: Challenges and Opportunities
Thanki, K., Blum, K. G., Thakur, A., Rose, F., & Foged, C. (2018) · Therapeutic Delivery · doi:10.4155/tde-2018-0029 · Cited by 25
RNAi therapeutic strategies for acute respiratory distress syndrome
Jagrosse, M. L., Dean, D. A., Rahman, A., & Nilsson, B. L. (2019) · Translational research · doi:10.1016/j.trsl.2019.07.011 · Cited by 25
Recent advances in dead cell clearance during acute lung injury and repair
Noone, P. M., & Reddy, S. P. (2021) · Faculty Reviews · doi:10.12703/r/10-33 · Cited by 21
Zakharova, L. Y., Pashirova, T. N., Kashapov, R. R., Gabdrakhmanov, D. R., & Sinyashin, O. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00024-5 · Cited by 20
Shear-responsive peptide/siRNA complexes as lung-targeting gene vectors
Yin, D., Zhang, M., Chen, J., Huang, Y., & Liang, D. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.12.005 · Cited by 20
Endosomal escape tendency of drug delivery systems to mediate cytosolic delivery of therapeutics
Bansal, S. K., Rajpoot, K., Sreeharsha, N., Youngren-Ortiz, S. R., Anup, N., & Tekade, R. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814455-8.00007-4 · Cited by 19
Acute respiratory distress syndrome
Wilkins, P. A., & Seahorn, T. L. (2004) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2003.11.001 · Cited by 19
Innovation in nanomedicine and engineered nanomaterials for therapeutic purposes
Galetti, M., Rossi, S., Caffarra, C., Gerbolés, A. G., & Miragoli, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814835-8.00009-1 · Cited by 16
Targeted Systemic Delivery of Therapeutic siRNA
Gujrati, M. D., & Lu, Z. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394295-1.00004-4 · Cited by 15
Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting System
Hayashi, Y., Hatakeyama, H., Kajimoto, K., Hyodo, M., Akita, H., & Harashima, H. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00184 · Cited by 14
RNA and CRISPR Interferences: Past, Present, and Future Perspectives
Sioud, M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0290-4_1 · Cited by 14
Delivering miRNA modulators for cancer treatment
Estanqueiro, M., Vasconcelos, M. H., Lobo, J. M. S., & Amaral, M. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813689-8.00014-8 · Cited by 12
Rai, D. B., Pooja, D., & Kulhari, H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814527-2.00009-3 · Cited by 12
Clinical translation of RNAi-based treatments for respiratory diseases
Ballarín-González, B., Thomsen, T., & Howard, K. A. (2012) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0098-7 · Cited by 10
Innovative nonviral vectors for small-interfering RNA delivery and therapy
Arruda, D. C., Hoffmann, C., Charrueau, C., Bigey, P., & Escriou, V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46142-9.00026-8 · Cited by 10
Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS)
Ostwani, W., & Shanley, T. P. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6356-5_7 · Cited by 8
RNA Interference – A Hallmark of Cellular Function and Gene Manipulation
Abdurakhmonov, I. Y. (2016) · InTech eBooks · doi:10.5772/62038 · Cited by 8
Targeting Promoter-Associated Noncoding RNA In Vivo
Civenni, G. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6716-2_15 · Cited by 8
Lipid nanoparticles as non-viral vectors for siRNA delivery
Petrilli, R., Eloy, J. O., de Souza, M. C., Barcellos, J. P. A., Marchetti, J. M., Yung, B. C., & Lee, R. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-42866-8.00003-4 · Cited by 8
Advanced Polymers for Nonviral Gene Delivery
Zhou, D., Zeng, M., Gao, Y., Sigen, A., Lyu, J., & Wang, W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814470-1.00010-1 · Cited by 8
Polyethylenimine nanoparticles
Nimesh, S. (2013) · Elsevier eBooks · doi:10.1533/9781908818645.197 · Cited by 8
Acute Respiratory Distress Syndrome
Zemans, R. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803809-3.00010-5 · Cited by 6
Pathophysiology of Acute Respiratory Distress Syndrome
Silva, P. L., & Rocco, P. R. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-41852-0_2 · Cited by 5
The Interface of Drug Delivery and Regenerative Medicine
Wechsler, M. E., Clegg, J. R., & Peppas, N. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11125-0 · Cited by 5
Acute Respiratory Distress Syndrome (ARDS): Definition, Incidence, and Outcome
Coudroy, R., Boissier, F., & Thille, A. W. (2017) · Springer eBooks · doi:10.1007/978-3-319-41852-0_1 · Cited by 4
Development and Deployment of Gene Therapies
Kili, S., & Chaffman, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-812034-7.00002-9 · Cited by 4
Acute Respiratory Distress Syndrome: Therapeutics, Pathobiology, and Prognosis
Vellingiri, V., Thirusangu, P., & Din, I. (2020) · Springer eBooks · doi:10.1007/978-981-15-3734-9_7 · Cited by 4
Polymeric Vectors for Strategic Delivery of Nucleic Acids
Dunn, A. W., & Shi, D. (2017) · Nano LIFE · doi:10.1142/s1793984417300035 · Cited by 3
Theory and limitations to gene therapy
Nimesh, S. (2013) · Elsevier eBooks · doi:10.1533/9781908818645.89 · Cited by 2
Birchler, J. A. (2010) · Wiley eBooks · doi:10.1002/9780470923733.ch1 · Cited by 2
Pathobiology of Pediatric Acute Respiratory Distress Syndrome
Smith, L. (2019) · Springer eBooks · doi:10.1007/978-3-030-21840-9_3 · Cited by 2
Lumb, A. B. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-2996-7.00031-3 · Cited by 1
Cited by
Zhu, J., Guo, M., Cui, Y., Meng, Y., Ding, J., Zeng, W., & Zhou, W. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c23069 · Cited by 46
Engineering exosomes for bone defect repair
Ma, S., Zhang, Y., Li, S., Li, A., Li, Y., & Pei, D. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1091360 · Cited by 38
Metadata
- Authors
- Zoulikha, M., Xiao, Q., Boafo, G. F., Sallam, M. A., Chen, Z., & He, W.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2022-02
- Volume
- 12
- Issue
- 2
- Pages
- 600-620
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W3195406917
- Cited by
- 275
- References
- 194
- FWCI
- 23.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.